Marie Jessen

MD | PhD fellow | Sepsis | Fluids | @RECEM_CFA @AarhusUni

[Marie Jessen @MarieKJessen]

@DrCheskes @AGN_Graz @johannes_wittig @SimonOrlob @EMManchester @g_lauridsen @SMcLeod_SREMI Was an absolute pleasure taking part in #Notfallmedizin2024 and meeting you all @DrCheskes @SMcLeod_SREMI @EMManchester and Bob Berg. Thanks for the invite @johannes_wittig, @SimonOrlob and @AGN_Graz 🙏🏻

[Asger Granfeldt @AsgerGranfeldt]

Today the Bicarbonate for In-Hospital Cardiac Arrest
– A Randomized, Double-Blind, Placebo-Controlled Trial started at Aarhus University Hospital. Soon it will be recruiting patients at 22 hospitals across Denmark https://t.co/cXT06uuFhN @LW_Andersen @nikostanko

[AEM Journal @AcademicEmerMed]

The #refacedsepsis feasibility trial reduced fluids in ED #sepsis patients w/o shock randomized to restrictive fluid administration or standard care in 24h. Study from @MarieKJessen and @RECEM_CFA. Read @ https://t.co/KthMkkjyRI.
#AEM #EM @thenntgroup @SAEMonline @srrezaie

[Marie Jessen @MarieKJessen]

@lpbentsen @MBrabrand Sådan 💪🏻👏🏻💸

[Critical Care Reviews @CritCareReviews]

#CLASSICtrial manuscript is now published @NEJM
https://t.co/ir0pETS1Rq

editorial - https://t.co/geoKIIIEtD

Many thanks @NEJM for facilitating the publication with the results presentation at #CCR22

@TineMeyhoff @AndersPerner @MortenHylander

[Marie Jessen @MarieKJessen]

Thanks to all participants and their families as well as doctors and nurses for their great support throughout the #refacedsepsis trial. Also, a huge thanks to all collaborators and supervisors!

@AUHdk @RandersHospital @HospitalsenhedM @RECEM_CFA

[Marie Jessen @MarieKJessen]

The results of the #refacedsepsis feasibility trial are now available.

24h crystalloid fluids were successfully reduced in sepsis patients without shock receiving restrictive fluids compared to standard care💦

🔗 https://t.co/PW9vmaqshH

@RECEM_CFA @AndersPerner @LarsWAndersen1

[Research Center for Emergency Medicine @RECEM_CFA]

A huge congratulations to @LarsWAndersen1 for receiving the The Anders Jahre Award for young researchers! 👏👏

Read more:
🔗https://t.co/Tp0Pv7FXSC (in Danish)
🔗https://t.co/rvLZe8Jxxh (in English)

[Sanne Møller Thysen @SThysen]

Stort tillykke med årets patientfokus til projektsygeplejerske Mia Blaabjerg fra Center for Akutforskning, @AUHdk
Mia har inddraget både patienter og pårørende i sin forskning.

[Carsten Meilandt @cmeilandt]

How is fluid therapy perceived by Danish ambulance clinicians? and how are we deciding when to administer fluids? Have a read @Arne49963641 @MarieKJessen
https://t.co/F0rfZiZ5U9

[Stine Fjendbo Galili @StineFGalili]

First 2 patients included in the KeTMo study💥
Could patients with a daily use of opiods benefit from a low-dose of ketamine when presenting at the ED? And what about all the other patients with severe acute pain? 💥
2/160
@RECEM_CFA
#emergencymedicine #painmedicine

[Research Center for Emergency Medicine @RECEM_CFA]

Two clinical trials from @RECEM_CFA are nominated for the best clinical trial in Denmark. 🏆

1⃣ @LarsWAndersen1 in the category: Investigator-initiated trials 🧑‍⚕️
2⃣ Mia Blaabjerg in the category: Patient focus 👥

Read more:
🔗https://t.co/I17f71b1Ho

🧵👇

[Marie Jessen @MarieKJessen]

Interesting: The #clovers trial (Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis) with 1,566 patients being treated for sepsis-induced hypotension ended early due to a lack of significant difference between 24-hour treatment strategies https://t.co/l9xYZju8HR

[Marie Jessen @MarieKJessen]

The REFACED Sepsis feasibility trial completed inclusion! 124 ED #sepsis patients w/o shock randomized to restrictive fluid administration or standard care in 24h💦 Thanks to all! #refacedsepsis @RECEM_CFA @AUHdk @RandersHospital @HospitalsenhedM @LarsWAndersen1 @AndersPerner

[Marie Jessen @MarieKJessen]

Only 10 to go 😅 114/124 patients randomized in the REFACED Sepsis trial. 24h Restrictive fluid administration vs standard care in ED Sepsis 💦 - a randomized feasibility trial @RECEM_CFA @AUHdk @RandersHospital @HospitalsenhedM

[British Journal of Anaesthesia @BJAJournals]

This systematic review and meta-analysis found that GDT during non-cardiac surgery might improve several patient-centered outcomes. However, certainty of evidence was only low to moderate
@BJAJournals @PeriOpQI @MarieKJessen @LarsWAndersen1

https://t.co/4pmKAGH6Si

[Marie Jessen @MarieKJessen]

100 patients randomized in the REFACED Sepsis trial 💦- 24 more to go… Restrictive Fluid Adm vs. Standard Care in ED Sepsis – a Multicenter, Randomized Feasibility Trial - investigating 24h crystalloid fluids #refacedsepsis @RECEM_CFA @AUHdk @RandersHospital @HospitalsenhedM

[Marie Jessen @MarieKJessen]

90/124 patients randomized in the REFACED Sepsis trial. 24h fluid administration vs standard care in ED sepsis 💦 - a feasibility trial #refacedsepsis @RECEM_CFA @AUHdk @RandersHospital @HospitalsenhedM

[Marie Jessen @MarieKJessen]

Fast inclusion - 64 patient randomized in the REFACED Sepsis feasibility trial - 60 to go 👏🏻 24h Restictive fluid administration vs standard of care in sepsis without shock 💦

[Marie Jessen @MarieKJessen]

54 patients randomized in the REFACED Sepsis trial - 70 to go 👏🏻 Restrictive fluid vs standard of care in sepsis without shock 💦@RECEM_CFA
Now enrolling at all three sites @AUHdk @RandersHospital @HospitalsenhedM